High-Risk Drug Monitoring Service · Ashby de La Zouch

High-Risk Drug Monitoring Service in Ashby de La Zouch.

Systematic monitoring of high-risk medicines across the practice list — DMARDs, lithium, amiodarone, anticoagulants, valproate — with pharmacist-led recall and prescribing safety reporting. Delivered to Ashby de La Zouch PCNs and GP practices from the BCS Halifax (West Yorkshire) hub, with paired cover from our Chiswick (West London) hub — the only UK dual-hub clinical pharmacy model.

Ashby de La Zouch · local context

Ashby de La Zouch PCNs sit within NHS Leicester, Leicestershire and Rutland ICB.

Ashby-de-la-Zouch PCNs sit on the Leicestershire–Derbyshire border with cross-trust discharge flow — BCS pharmacists work both UHL and UHDB clinic letters through a single reconciliation workflow.

For high-risk drug monitoring specifically, the Ashby de La Zouch pathway typically integrates with University Hospitals of Leicester and Burton (UHDB). BCS standardises the cross-organisation workflow into a single hub-supervised process.

What you get

What high-risk drug monitoring in Ashby de La Zouch actually looks like.

  • Quarterly DMARD bloods recall and recording
  • Anticoagulant INR / DOAC reviews
  • Lithium and amiodarone monitoring cycles
  • Valproate Pregnancy Prevention Programme oversight
  • Safety alert action and audit evidence

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every high-risk drug monitoring placement in Ashby de La Zouch is mobilised from one of our two clinical hubs — Halifax (West Yorkshire) as the lead and Chiswick (West London) as paired cover. The dual-hub model is unique to BCS: same SOPs, same supervision, same-week cross-cover.

  • Lead delivery from the BCS Halifax (West Yorkshire) hub
  • Paired cover from BCS Chiswick (West London)
  • Same-week sickness, leave and maternity cover
  • ARRS-compliant, GPhC-registered workforce
  • One SLA, one report, one escalation point

Ashby de La Zouch · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in Ashby de La Zouch
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why Ashby de La Zouch PCNs choose BCS for high-risk drug monitoring.

Solo recruitment for high-risk drug monitoring in Ashby de La Zouch leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Halifax (West Yorkshire)/Chiswick (West London) dual-hub.

Frequently asked questions — High-Risk Drug Monitoring Service in Ashby de La Zouch.

Does BCS handle MHRA safety alert response?+

Yes — every active MHRA alert is mapped to a BCS pharmacist workflow with action evidence per practice.

Does BCS already deliver high-risk drug monitoring in Ashby de La Zouch?+

BCS supports PCNs across East Midlands from our Halifax (West Yorkshire) hub with paired cover from Chiswick (West London), and is actively delivering or available to mobilise high-risk drug monitoring in Ashby de La Zouch. Get in touch and we'll confirm current capacity.

How quickly can BCS mobilise high-risk drug monitoring in Ashby de La Zouch?+

In most cases inside 4–6 weeks of contract sign-off, with HSCN-secured remote prescribing back-up available sooner where capacity is urgent.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call